Takeda Pharmaceutical Company Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Takeda Pharmaceutical Company stocks.

Recent Signals

Date Stock Signal Type
2021-06-11 ALNY Golden Cross Bullish
2021-06-11 ALNY New Uptrend Bullish
2021-06-11 ALNY Upper Bollinger Band Walk Strength
2021-06-11 AMGN 20 DMA Support Bullish
2021-06-11 AMGN Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2021-06-11 CRDF Bollinger Band Squeeze Range Contraction
2021-06-11 CRDF 20 DMA Resistance Bearish
2021-06-11 GOSS Fell Below 20 DMA Bearish
2021-06-11 ITCI Bearish Engulfing Bearish
2021-06-11 ITCI New 52 Week High Strength
2021-06-11 ITCI Upper Bollinger Band Walk Strength
2021-06-11 ITCI Slingshot Bullish Bullish Swing Setup
2021-06-11 LXRX Upper Bollinger Band Walk Strength
2021-06-11 LXRX MACD Bullish Centerline Cross Bullish
2021-06-11 LXRX 50 DMA Support Bullish
2021-06-11 OVID Narrow Range Bar Range Contraction
2021-06-11 OVID NR7 Range Contraction
2021-06-11 OVID NR7-2 Range Contraction
2021-06-11 RXRX Pocket Pivot Bullish Swing Setup
2021-06-11 STTK Crossed Above 50 DMA Bullish
2021-06-11 TYME 20 DMA Support Bullish
2021-06-11 TYME 50 DMA Support Bullish
2021-06-11 TYME 200 DMA Support Bullish
2021-06-11 TYME Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2021-06-11 XOMA Bollinger Band Squeeze Range Contraction
2021-06-11 XOMA Non-ADX 1,2,3,4 Bearish Bearish Swing Setup

Takeda Pharmaceutical Company Stocks Recent News

Date Stock Title
Jun 13 TAK The Week Ahead In Biotech: Takeda, Blueprint Medicines, Orphazyme, Eton On The Radar Ahead Of FDA Decisions, IPOs
Jun 11 TYME Tyme Technologies, Inc. 2021 Q4 - Results - Earnings Call Presentation
Jun 11 TYME Tyme Stock Is Trading Higher On Pipeline Update After Strategic Review, Q4 Earnings
Jun 11 TYME Tyme Technologies, Inc. (TYME) CEO Richie Cunningham on Q1 2021 Results - Earnings Call Transcript
Jun 10 TYME Tyme Technologies rises on pipeline update
Jun 10 TYME Tyme Technologies reports FY results
Jun 10 TYME Tyme Technologies, Inc. Completes Strategic Review, Announces OASIS Breast Trial With Georgetown University, and Reports Fiscal Year 2021 Financial Results
Jun 10 CRDF Cardiff Oncology Announces the Appointment of Two New Independent Members to its Board of Directors
Jun 10 TYME Earnings Scheduled For June 10, 2021
Jun 9 AMGN Amgen Inc. (AMGN) Management Presents at Goldman Sachs 42nd Annual Global Healthcare Conference (Transcript)
Jun 9 TAK Takeda introduces the In Their Shoes experience to the Middle East in support of the IBD patient community
Jun 8 XOMA XOMA Corporation (NASDAQ:XOMA) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?
Jun 8 AMGN Biogen gets FDA approval for Alzheimer's treatment
Jun 8 ITCI The Daily Biotech Pulse: Hookipa, PDS Biotech Report Positive Data, Ironwood CFO To Depart, Decision Day For Vertex
Jun 8 CRDF Cardiff Oncology starts dosing in mid-stage pancreatic ductal adenocarcinoma study
Jun 8 CRDF Cardiff Oncology Announces First Patient Dosed in a Phase 2 Trial of Onvansertib in Combination with Irinotecan and 5-FU in Pancreatic Cancer
Jun 7 AMGN 5 Top ETFs With Exposure To Biogen
Jun 7 AMGN Amgen's Sotorasib is First KRAS Inhibitor to Show Overall Survival Benefit in Lung Cancer With KRAS Mutations
Jun 7 AMGN Merus upgraded on ASCO update, Cantor favors Harpoon after selloff; and more in today’s analyst action
Jun 7 TAK Phase 3 Clinical Trial Subgroup Analysis Across Solid Organ Transplant (SOT) Types Supports Efficacy of Maribavir Over Conventional Therapies in Post-Transplant Recipients With Cytomegalovirus (CMV) Infection (Refractory, With or Without Resistance)

The Takeda Pharmaceutical Company Limited (武田薬品工業株式会社, Takeda Yakuhin Kōgyō kabushiki gaisha) [takeꜜda jakɯçiŋ koꜜːɡʲoː] is a Japanese multinational pharmaceutical and biopharmaceutical company. It is the largest pharmaceutical company in Asia and one of the top 20 largest pharmaceutical companies in the world by revenue (top 10 following merger with Shire). The company has over 49,578 employees worldwide and achieved US $19.299 billion in revenue during the 2018 fiscal year. The company is focused on metabolic disorders, gastroenterology, neurology, inflammation, as well as oncology through its independent subsidiary, Takeda Oncology. Its headquarters is located in Chuo-ku, Osaka, and it has an office in Nihonbashi, Chuo, Tokyo.
In January 2012, Fortune Magazine ranked the Takeda Oncology Company as one of the 100 best companies to work for in the United States.

More about Takeda Pharmaceutical Company
Browse All Tags